Together we can make RET-positive cancer a chronic disease! 

RET is a mutation of the RET gene that results in cancer cells to multiply and spread. RET alterations occur in 2% of non-small cell lung cancers (NSCLC), with a higher percentage of patients being younger (<60) and never-smokers.

RET alterations occur in papillary thyroid cancers, a majority of advanced sporadic medullary thyroid cancers, as well as many other cancers, including pancreatic, colorectal, bladder and breast.

Your donation helps patients like Brittany

Brittany is a stage IV RET-positive NSCLC survivor who was diagnosed in 2021 and was 36 years old at diagnosis. Read her story here.

RET-specific medical research is vital

RET patients are counting on the development of new medications to overcome resistance mechanisms and, someday, make RET-positive cancer a chronic disease that can be controlled with life-long daily medication.

RETpositive is working to make RET-fusion cancers a chronic disease through awareness, research and patient support.

We support research that will advance our understanding of RET-driven cancers and increase the number and quality of cancer treatments for all RET patients.

Over $2.2 million co-funded for medical research since 2022.

Every donation no matter how big or small makes a difference!